» Articles » PMID: 33776772

4-Chlorothymol Exerts Antiplasmodial Activity Impeding Redox Defense System in

Overview
Journal Front Pharmacol
Date 2021 Mar 29
PMID 33776772
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Malaria remains one of the major health concerns due to the resistance of species toward the existing drugs warranting an urgent need for new antimalarials. Thymol derivatives were known to exhibit enhanced antimicrobial activities; however, no reports were found against spp. In the present study, the antiplasmodial activity of thymol derivatives was evaluated against chloroquine-sensitive (NF-54) and -resistant (K1) strains of . Among the thymol derivatives tested, 4-chlorothymol showed potential activity against sensitive and resistant strains of . 4-Chlorothymol was found to increase the reactive oxygen species and reactive nitrogen species level. Furthermore, 4-chlorothymol could perturb the redox balance by modulating the enzyme activity of GST and GR. 4-Chlorothymol also showed synergy with chloroquine against chloroquine-resistant . 4-Chlorothymol was found to significantly suppress the parasitemia and increase the mean survival time in assays. Interestingly, in assay, 4-chlorothymol in combination with chloroquine showed higher chemosuppression as well as enhanced mean survival time at a much lower concentration as compared to individual doses of chloroquine and 4-chlorothymol. These observations clearly indicate the potential use of 4-chlorothymol as an antimalarial agent, which may also be effective in combination with the existing antiplasmodial drugs against chloroquine-resistant infection. cytotoxicity/hemolytic assay evidently suggests that 4-chlorothymol is safe for further exploration of its therapeutic properties.

Citing Articles

In vitro efficacy of plumbagin and thymol against .

Titus E, Palavesam A, Rajaram S, Perumal P, Darwin S, Sanmugapriya N J Parasit Dis. 2023; 47(1):152-160.

PMID: 36910313 PMC: 9998759. DOI: 10.1007/s12639-022-01550-x.


Dinuclear and mononuclear metal(II) polypyridyl complexes against drug-sensitive and drug-resistant Plasmodium falciparum and their mode of action.

Lai J, Maah M, Tan K, Sarip R, Lim Y, Ganguly R Malar J. 2022; 21(1):386.

PMID: 36528584 PMC: 9758846. DOI: 10.1186/s12936-022-04406-0.

References
1.
Fivelman Q, Adagu I, Warhurst D . Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum. Antimicrob Agents Chemother. 2004; 48(11):4097-102. PMC: 525430. DOI: 10.1128/AAC.48.11.4097-4102.2004. View

2.
Kumar S, Guha M, Choubey V, Maity P, Srivastava K, Puri S . Bilirubin inhibits Plasmodium falciparum growth through the generation of reactive oxygen species. Free Radic Biol Med. 2007; 44(4):602-13. DOI: 10.1016/j.freeradbiomed.2007.10.057. View

3.
Muller S . Redox and antioxidant systems of the malaria parasite Plasmodium falciparum. Mol Microbiol. 2004; 53(5):1291-305. DOI: 10.1111/j.1365-2958.2004.04257.x. View

4.
van Dooren G, Stimmler L, McFadden G . Metabolic maps and functions of the Plasmodium mitochondrion. FEMS Microbiol Rev. 2006; 30(4):596-630. DOI: 10.1111/j.1574-6976.2006.00027.x. View

5.
Khare S, Gupta M, Cheema H, Maurya A, Rout P, Darokar M . Rosa damascena restrains Plasmodium falciparum progression in vitro and impedes malaria pathogenesis in murine model. Biomed Pharmacother. 2018; 97:1654-1662. DOI: 10.1016/j.biopha.2017.11.130. View